https://hstalks.com/therapeutic-area/7/neurology/?biosci New and updated series & talks on Neurology from HSTalks' Biomedical & Life Sciences Collection. daily 1 2006-01-01T12:00+00:00 Henry Stewart Talks en © Copyright Henry Stewart Talks Ltd. The Biomedical & Life Sciences Collection © Copyright Henry Stewart Talks Ltd. https://hstalks.com/t/24732/facial-muscles-and-innervation/?biosci Facial muscle anatomy - Muscle function and expressions - Facial nerve structure - Major facial muscles roles - Facial muscle disorders - Clinical signs and diagnosis - Central vs peripheral nerve lesions Facial muscles and innervation Facial muscle anatomy, Muscle function and expressions, Facial nerve structure, Major facial muscles roles, Facial muscle disorders, Clinical signs and diagnosis, Central vs peripheral nerve lesions 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/20617/cell-replacement-therapy-for-neurodegenerative-dis/?biosci Huntington’s disease (HD) - Genetics, symptoms and pathology of HD - Transplants in HD - Stem cell derived medium spiny neurons - hPSC-derived medium spiny neurons Cell replacement therapy for neurodegenerative diseases 2 Dr. Mariah J. Lelos Huntington’s disease (HD), Genetics, symptoms and pathology of HD, Transplants in HD, Stem cell derived medium spiny neurons, hPSC-derived medium spiny neurons 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/24740/mental-health-nursing/?biosci Intro to Mental Health Nursing - Assessment Techniques - Therapeutic Communication - Person-Centred Care - Crisis Intervention - Teamwork in Mental Health Nursing Mental health nursing Intro to Mental Health Nursing, Assessment Techniques, Therapeutic Communication, Person-Centred Care, Crisis Intervention, Teamwork in Mental Health Nursing 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/23389/unlocking-a-cryptic-pocket-a-new-approach-to-safer/?biosci CB1 receptor agonists - Cryptic pocket drug design - Molecular dynamics simulations - Peripheral pain therapeutics - Biased GPCR signalling - Tolerance reduction in cannabinoid therapies - Allosteric/sodium binding sites - Translation of analgesic drug candidates (VIP36) to the clinic Unlocking a cryptic pocket: a new approach to safer pain relief Prof. Susruta Majumdar Dr. Vipin Ashok Rangari CB1 receptor agonists, Cryptic pocket drug design, Molecular dynamics simulations, Peripheral pain therapeutics, Biased GPCR signalling, Tolerance reduction in cannabinoid therapies, Allosteric/sodium binding sites, Translation of analgesic drug candidates (VIP36) to the clinic 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/18670/pathophysiology-and-management-of-chronic-inflamma/?biosci Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - CIDP pathology - CIDP immunopathogenesis - CIDP treatment goals - Intravenous immunoglobulin (IVIG) - Plasma exchange (PLEX) - Corticosteroid (CSS) - Subcutaneous immunoglobulin (SCIG) - Neonatal Fc receptor inhibitors - Complement inhibitors Pathophysiology and management of chronic inflammatory demyelinating polyneuropathy Prof. Urvi Desai Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), CIDP pathology, CIDP immunopathogenesis, CIDP treatment goals, Intravenous immunoglobulin (IVIG), Plasma exchange (PLEX), Corticosteroid (CSS), Subcutaneous immunoglobulin (SCIG), Neonatal Fc receptor inhibitors, Complement inhibitors 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/20584/cell-replacement-therapy-for-neurodegenerative-dis/?biosci Overview of cell replacement therapies - Parkinsons’s disease (PD) and current treatments - Parkinson’s graft model - Dopamine grafts improve motor deficits - First PD clinical trials with fetal grafts - Generating stem cell derived dopamine neurons - Stem cell dopamine grafts - First-in-person clinical trials Cell replacement therapy for neurodegenerative diseases 1 Dr. Mariah J. Lelos Overview of cell replacement therapies, Parkinsons’s disease (PD) and current treatments, Parkinson’s graft model, Dopamine grafts improve motor deficits, First PD clinical trials with fetal grafts, Generating stem cell derived dopamine neurons, Stem cell dopamine grafts, First-in-person clinical trials 2026-07-30 2026-07-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/22532/action-potentials-and-synaptic-transmission/?biosci Resting membrane potential - Action potential phases - Myelination and refractory periods - Synaptic transmission mechanisms - Postsynaptic integration - Effects of drugs and diseases on neural signals Action potentials and synaptic transmission Resting membrane potential, Action potential phases, Myelination and refractory periods, Synaptic transmission mechanisms, Postsynaptic integration, Effects of drugs and diseases on neural signals 2026-06-30 2026-06-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/22533/neurodevelopment-and-disorders/?biosci Neurodevelopment stages - Genetic and environmental factors - Neurogenesis, synaptogenesis, critical periods - Neurodevelopmental disorders causes - Early identification and intervention - Plasticity and prevention in neurodevelopment Neurodevelopment and disorders Neurodevelopment stages, Genetic and environmental factors, Neurogenesis, synaptogenesis, critical periods, Neurodevelopmental disorders causes, Early identification and intervention, Plasticity and prevention in neurodevelopment 2026-06-30 2026-06-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/19957/interpreting-non-clinical-toxicity-studies-in-psyc/?biosci Psychiatric drug development - Challenges in early drug development - Challenges associated with lifelong treatment - Non-clinical toxicity studies - Toxicity studies for psychiatric therapeutics - Relevance to human safety Interpreting non-clinical toxicity studies in psychiatric drug development: human relevance and safety Dr. Yael Mandelblat-Cerf Psychiatric drug development, Challenges in early drug development, Challenges associated with lifelong treatment, Non-clinical toxicity studies, Toxicity studies for psychiatric therapeutics, Relevance to human safety 2026-06-30 2026-06-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/20089/brain-aging-at-a-crossroads-where-do-we-go-from-th/?biosci Oxidative stress - Possible mechanism of oxidative damage - Change in mitochondria in Alzheimer’s disease - Amyloid precursor protein (APP) induced mitochondrial abnormalities - Amyloid β and oxidative damage - NFT and oxidative damage - Metal binding and oxidation of amyloid β - Metalloproteins in AD - Role of amyloid β in metal-mediated radical formation Brain aging at a crossroads: where do we go from three decades of failed therapeutics? Prof. George Perry Oxidative stress, Possible mechanism of oxidative damage, Change in mitochondria in Alzheimer’s disease, Amyloid precursor protein (APP) induced mitochondrial abnormalities, Amyloid β and oxidative damage, NFT and oxidative damage, Metal binding and oxidation of amyloid β, Metalloproteins in AD, Role of amyloid β in metal-mediated radical formation 2026-06-30 2026-06-30 The Biomedical & Life Sciences Collection https://hstalks.com/t/22300/duchenne-muscular-dystrophy-pathology-diagnostic-s/?biosci Duchenne muscular dystrophy (DMD) pathology - Dystrophin structure and function - DMD genetics - Muscle degeneration - Fibrosis progression - Cardiomyopathy in DMD - Exon skipping therapy - Genetic diagnosis - Early intervention Duchenne muscular dystrophy: pathology, diagnostic strategies, and core molecular pathways Prof. Steve Wilton Duchenne muscular dystrophy (DMD) pathology, Dystrophin structure and function, DMD genetics, Muscle degeneration, Fibrosis progression, Cardiomyopathy in DMD, Exon skipping therapy, Genetic diagnosis, Early intervention 2026-06-30 2026-06-30 The Biomedical & Life Sciences Collection